Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for Chemotherapy-Induced Nausea in Breast Cancer
NCT00206440Phase 3Terminated
- Sponsor
- Baylor Breast Care Center
- Start
- Aug 2005
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chemotherapy-induced nausea and vomiting (CINV) comparing Esomeprazole with Placebo (2 arms). Primary endpoint: Number of Times a Subject Felt Sick to Her Stomach and Number of Times a Subject Required Rescue Medication. Started Aug 2005; status: terminated.
02
Drugs
esomeprazole
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00206440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206440.